Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Muslum Akgoz is active.

Publication


Featured researches published by Muslum Akgoz.


Food Chemistry | 2017

Comparison of DNA extraction methods for meat analysis

Burhanettin Yalçınkaya; Eylem Yumbul; Erkan Mozioğlu; Muslum Akgoz

Preventing adulteration of meat and meat products with less desirable or objectionable meat species is important not only for economical, religious and health reasons, but also, it is important for fair trade practices, therefore, several methods for identification of meat and meat products have been developed. In the present study, ten different DNA extraction methods, including Tris-EDTA Method, a modified Cetyltrimethylammonium Bromide (CTAB) Method, Alkaline Method, Urea Method, Salt Method, Guanidinium Isothiocyanate (GuSCN) Method, Wizard Method, Qiagen Method, Zymogen Method and Genespin Method were examined to determine their relative effectiveness for extracting DNA from meat samples. The results show that the salt method is easy to perform, inexpensive and environmentally friendly. Additionally, it has the highest yield among all the isolation methods tested. We suggest this method as an alternative method for DNA isolation from meat and meat products.


BMC Infectious Diseases | 2016

The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis

Alison S. Devonshire; Denise M. O’Sullivan; Isobella Honeyborne; Gerwyn M. Jones; Maria Karczmarczyk; Jernej Pavšič; Alice Gutteridge; Mojca Milavec; Pablo Mendoza; Heinz Schimmel; Fran Van Heuverswyn; Rebecca Gorton; Daniela M. Cirillo; Emanuele Borroni; Kathryn Harris; Marinus Barnard; Anthenette Heydenrych; Norah Ndusilo; Carole L. Wallis; Keshree Pillay; Thomas Barry; Kate Reddington; Elvira Richter; Erkan Mozioğlu; Sema Akyürek; Burhanettin Yalçınkaya; Muslum Akgoz; Jana Žel; Carole A. Foy; Timothy D. McHugh

BackgroundReal-time PCR (qPCR) based methods, such as the Xpert MTB/RIF, are increasingly being used to diagnose tuberculosis (TB). While qualitative methods are adequate for diagnosis, the therapeutic monitoring of TB patients requires quantitative methods currently performed using smear microscopy. The potential use of quantitative molecular measurements for therapeutic monitoring has been investigated but findings have been variable and inconclusive. The lack of an adequate reference method and reference materials is a barrier to understanding the source of such disagreement. Digital PCR (dPCR) offers the potential for an accurate method for quantification of specific DNA sequences in reference materials which can be used to evaluate quantitative molecular methods for TB treatment monitoring.MethodsTo assess a novel approach for the development of quality assurance materials we used dPCR to quantify specific DNA sequences in a range of prototype reference materials and evaluated accuracy between different laboratories and instruments. The materials were then also used to evaluate the quantitative performance of qPCR and Xpert MTB/RIF in eight clinical testing laboratories.ResultsdPCR was found to provide results in good agreement with the other methods tested and to be highly reproducible between laboratories without calibration even when using different instruments. When the reference materials were analysed with qPCR and Xpert MTB/RIF by clinical laboratories, all laboratories were able to correctly rank the reference materials according to concentration, however there was a marked difference in the measured magnitude.ConclusionsTB is a disease where the quantification of the pathogen could lead to better patient management and qPCR methods offer the potential to rapidly perform such analysis. However, our findings suggest that when precisely characterised materials are used to evaluate qPCR methods, the measurement result variation is too high to determine whether molecular quantification of Mycobacterium tuberculosis would provide a clinically useful readout. The methods described in this study provide a means by which the technical performance of quantitative molecular methods can be evaluated independently of clinical variability to improve accuracy of measurement results. These will assist in ultimately increasing the likelihood that such approaches could be used to improve patient management of TB.


Talanta | 2016

Voltammetric detection of sequence-selective DNA hybridization related to Toxoplasma gondii in PCR amplicons.

Gültekin Gökçe; Arzum Erdem; Çağdaş Ceylan; Muslum Akgoz

This work describes the single-use electrochemical DNA biosensor technology developed for voltammetric detection of sequence selective DNA hybridization related to important human and veterinary pathogen; Toxoplasma gondii. In the principle of electrochemical label-free detection assay, the duplex of DNA hybrid formation was detected by measuring guanine oxidation signal occured in the presence of DNA hybridization. The biosensor design consisted of the immobilization of an inosine-modified (guanine-free) probe onto the surface of pencil graphite electrode (PGE), and the detection of the duplex formation in connection with the differential pulse voltammetry(DPV) by measuring the guanine signal. Toxoplasma gondii capture probe was firstly immobilized onto the surface of the activated PGE by wet adsorption. The extent of hybridization at PGE surface between the probe and the target was then determined by measuring the guanine signal observed at +1.0V. The electrochemical monitoring of optimum DNA hybridization has been performed in the target concentration of 40µg/mL in 50min of hybridization time. The specificity of the electrochemical biosensor was then tested using non-complementary, or mismatch short DNA sequences. Under the optimum conditions, the guanine oxidation signal indicating full hybridization was measured in various target concentration from 0.5 to 25µg/mL and a detection limit was found to be 1.78µg/mL. This single-use biosensor platform was successfully applied for the voltammetric detection of DNA hybridization related to Toxoplasma gondii in PCR amplicons.


PLOS ONE | 2016

Proteomic Analysis of Kidney Preservation Solutions Prior to Renal Transplantation.

Abdurrahman Coskun; Ahmet Tarik Baykal; Dilek Kazan; Muslum Akgoz; Merve Oztug Senal; Ibrahim Berber; I. Titiz; Gokhan Bilsel; Hakan Kilercik; Kübra Karaosmanoğlu; Muslum Cicek; Ilknur Yurtsever; Cevat Yazıcı; Niels Olsen Saraiva Câmara

One of the main issues in kidney transplantation is the optimal functional preservation of the organ until its transplantation into the appropriate recipient. Despite intensive efforts, the functional preservation period remains limited to hours. During this time, as a result of cellular injury, various proteins, peptides, and other molecules are released by the organ into the preservation medium. In this study, we used proteomic techniques to analyze the protein profiles of preservation solutions in which organs had been preserved prior to their transplantation. Samples were obtained from the preservation solutions of 25 deceased donor kidneys scheduled for transplantation. The protein profiles of the solutions were analyzed using 2D gel electrophoresis/MALDI-TOF and LC-MS/MS. We identified and quantified 206 proteins and peptides belonging to 139 different groups. Of these, 111 proteins groups were belonging to kidney tissues. This study used proteomic techniques to analyze the protein profiles of organ preservation solutions. These findings will contribute to the development of improved preservation solutions to effectively protect organs for transplantation.


Analytical and Bioanalytical Chemistry | 2017

Inter-laboratory assessment of different digital PCR platforms for quantification of human cytomegalovirus DNA

Jernej Pavšič; Alison S. Devonshire; Andrej Blejec; Carole A. Foy; Fran Van Heuverswyn; Gerwyn M. Jones; Heinz Schimmel; Jana Žel; Jim F. Huggett; Nicholas Redshaw; Maria Karczmarczyk; Erkan Mozioğlu; Sema Akyürek; Muslum Akgoz; Mojca Milavec

Quantitative PCR (qPCR) is an important tool in pathogen detection. However, the use of different qPCR components, calibration materials and DNA extraction methods reduces comparability between laboratories, which can result in false diagnosis and discrepancies in patient care. The wider establishment of a metrological framework for nucleic acid tests could improve the degree of standardisation of pathogen detection and the quantification methods applied in the clinical context. To achieve this, accurate methods need to be developed and implemented as reference measurement procedures, and to facilitate characterisation of suitable certified reference materials. Digital PCR (dPCR) has already been used for pathogen quantification by analysing nucleic acids. Although dPCR has the potential to provide robust and accurate quantification of nucleic acids, further assessment of its actual performance characteristics is needed before it can be implemented in a metrological framework, and to allow adequate estimation of measurement uncertainties. Here, four laboratories demonstrated reproducibility (expanded measurement uncertainties below 15%) of dPCR for quantification of DNA from human cytomegalovirus, with no calibration to a common reference material. Using whole-virus material and extracted DNA, an intermediate precision (coefficients of variation below 25%) between three consecutive experiments was noted. Furthermore, discrepancies in estimated mean DNA copy number concentrations between laboratories were less than twofold, with DNA extraction as the main source of variability. These data demonstrate that dPCR offers a repeatable and reproducible method for quantification of viral DNA, and due to its satisfactory performance should be considered as candidate for reference methods for implementation in a metrological framework.


Biomolecular Detection and Quantification | 2016

An international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1

Alison S. Devonshire; Rebecca Sanders; Alexandra S. Whale; Gavin Nixon; Simon Cowen; Stephen L. R. Ellison; Helen C. Parkes; P. Scott Pine; Marc L. Salit; Jennifer H. McDaniel; Sarah A. Munro; Steve Lund; Satoko Matsukura; Yuji Sekiguchi; Mamoru Kawaharasaki; José Mauro Granjeiro; Priscila Falagan-Lotsch; Antonio Marcos Saraiva; Paulo Couto; Inchul Yang; Hyerim Kwon; Sang-Ryoul Park; Tina Demšar; Jana Žel; Andrej Blejec; Mojca Milavec; Lianhua Dong; Ling Zhang; Zhiwei Sui; Jing Wang

Measurement of RNA can be used to study and monitor a range of infectious and non-communicable diseases, with profiling of multiple gene expression mRNA transcripts being increasingly applied to cancer stratification and prognosis. An international comparison study (Consultative Committee for Amount of Substance (CCQM)-P103.1) was performed in order to evaluate the comparability of measurements of RNA copy number ratio for multiple gene targets between two samples. Six exogenous synthetic targets comprising of External RNA Control Consortium (ERCC) standards were measured alongside transcripts for three endogenous gene targets present in the background of human cell line RNA. The study was carried out under the auspices of the Nucleic Acids (formerly Bioanalysis) Working Group of the CCQM. It was coordinated by LGC (United Kingdom) with the support of National Institute of Standards and Technology (USA) and results were submitted from thirteen National Metrology Institutes and Designated Institutes. The majority of laboratories performed RNA measurements using RT-qPCR, with datasets also being submitted by two laboratories based on reverse transcription digital polymerase chain reaction and one laboratory using a next-generation sequencing method. In RT-qPCR analysis, the RNA copy number ratios between the two samples were quantified using either a standard curve or a relative quantification approach. In general, good agreement was observed between the reported results of ERCC RNA copy number ratio measurements. Measurements of the RNA copy number ratios for endogenous genes between the two samples were also consistent between the majority of laboratories. Some differences in the reported values and confidence intervals (‘measurement uncertainties’) were noted which may be attributable to choice of measurement method or quantification approach. This highlights the need for standardised practices for the calculation of fold change ratios and uncertainties in the area of gene expression profiling.


Metrologia | 2012

CCQM-K86/P113.1: Relative quantification of genomic DNA fragments extracted from a biological tissue

Philippe Corbisier; S Vincent; H Schimmel; A-M Kortekaas; S Trapmann; Malcolm Burns; C Bushell; Muslum Akgoz; Sema Akyürek; Lianhua Dong; B Fu; Ling Zhang; Jing Wang; M Pérez Urquiza; J L Bautista; A Garibay; B Fuller; Anna Baoutina; Lina Partis; Kerry R. Emslie; Marcia J. Holden; W Y Chum; H-H Kim; N Phunbua; Mojca Milavec; J Zel; Maxim Vonsky; L A Konopelko; T L T Lau; B Yang

Key comparison CCQM-K86 was performed to demonstrate and document the capacity of interested national metrology institutes (NMIs) and designated institutes (DIs) in the determination of the relative quantity of two specific genomic DNA fragments present in a biological tissue. The study provides the support for the following measurement claim: Quantification of the ratio of the number of copies of specified intact sequence fragments of a length in the range of 70 to 100 nucleotides in a single genomic DNA extract from ground maize seed materials. The study was carried out under the auspices of the Bioanalysis Working Group (BAWG) of the Comit? Consultatif pour la Quantit? de Mati?re (CCQM) and was piloted by the Institute for Reference Materials and Methods (IRMM) in Geel (Belgium). The following laboratories (in alphabetical order) participated in this key comparison: AIST (Japan), CENAM (Mexico), DMSc (Thailand), GLHK (Hong Kong), IRMM (European Union), KRISS (Republic of Korea), LGC (United Kingdom), MIRS/NIB (Slovenia), NIM (PR China), NIST (USA), NMIA (Australia), T?BITAK UME (Turkey) and VNIIM (Russian Federation). The following laboratories (in alphabetical order) participated in a pilot study that was organized in parallel: LGC (United Kingdom), PKU (PR China), NFRI (Japan) and NIMT (Thailand). Good agreement was observed between the reported results of eleven participants. Main text. To reach the main text of this paper, click on Final Report. Note that this text is that which appears in Appendix B of the BIPM key comparison database kcdb.bipm.org/. The final report has been peer-reviewed and approved for publication by the CCQM, according to the provisions of the CIPM Mutual Recognition Arrangement (MRA).


Clinical Chemistry | 2018

Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine

Alexandra S. Whale; Gerwyn M. Jones; Jernej Pavšič; Tanja Dreo; Nicholas Redshaw; Sema Akyürek; Muslum Akgoz; Carla Divieto; Maria Paola Sassi; Hua-Jun He; Kenneth D. Cole; Young-Kyung Bae; Sang-Ryoul Park; Liesbet Deprez; Philippe Corbisier; Sonia Garrigou; Valérie Taly; Raquel Larios; Simon Cowen; Denise M. O'Sullivan; Claire A. Bushell; Heidi Goenaga-Infante; Carole A. Foy; Alison Woolford; Helen C. Parkes; Jim F. Huggett; Alison S. Devonshire

BACKGROUND Genetic testing of tumor tissue and circulating cell-free DNA for somatic variants guides patient treatment of many cancers. Such measurements will be fundamental in the future support of precision medicine. However, there are currently no primary reference measurement procedures available for nucleic acid quantification that would support translation of tests for circulating tumor DNA into routine use. METHODS We assessed the accuracy of digital PCR (dPCR) for copy number quantification of a frequently occurring single-nucleotide variant in colorectal cancer (KRAS c.35G>A, p.Gly12Asp, from hereon termed G12D) by evaluating potential sources of uncertainty that influence dPCR measurement. RESULTS Concentration values for samples of KRAS G12D and wild-type plasmid templates varied by <1.2-fold when measured using 5 different assays with varying detection chemistry (hydrolysis, scorpion probes, and intercalating dyes) and <1.3-fold with 4 commercial dPCR platforms. Measurement trueness of a selected dPCR assay and platform was validated by comparison with an orthogonal method (inductively coupled plasma mass spectrometry). The candidate dPCR reference measurement procedure showed linear quantification over a wide range of copies per reaction and high repeatability and interlaboratory reproducibility (CV, 2%-8% and 5%-10%, respectively). CONCLUSIONS This work validates dPCR as an SI-traceable reference measurement procedure based on enumeration and demonstrates how it can be applied for assignment of copy number concentration and fractional abundance values to DNA reference materials in an aqueous solution. High-accuracy measurements using dPCR will support the implementation and traceable standardization of molecular diagnostic procedures needed for advancements in precision medicine.


Analytical Methods | 2016

Detection of nuclease activity using a simple fluorescence based biosensor

Erkan Mozioğlu; Muslum Akgoz; Tanıl Kocagöz; Candan Tamerler

Nucleases are associated with a variety of diseases as they catalyze the degradation of nucleic acids. Their presence as a contaminant could also be a major concern in several molecular biology-related analyses where DNAse and RNAse free environments are required. Here, we report a simple, fluorescence-based biosensor for nuclease detection. The sensor utilizes only one fluorescent molecule attached to a ssDNA molecule building upon a fluorescence-quenching phenomenon taking place between a fluorescent dye and a nucleotide base. The intensity of the fluorescent molecule is quenched by covalently attaching to ssDNA and upon digestion of the ssDNA the fluorescence signal increases dramatically. Consequently, the fluorescence signal can be used to determine the activity of nuclease enzymes for a variety of applications ranging from molecular biology to clinical diagnostics. Compared to available methods, our sensor does not use any additional substances such as cationic polymers, carbon nanotubes or nanoparticles, graphene oxide or silver nanoclusters or a quencher like DABCYL to quench a fluorophore. The simplicity of the detection method makes this an attractive sensor as a low cost, fast and convenient system that can be incorporated into multiple readers for widespread use in virtually all molecular biology-related analyses.


Medicine Science | International Medical Journal | 2018

Effect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicity

Zeynal Karaca; Hasan Özen; Muslum Akgoz; Yilmaz Cigremis

Vascular endothelial growth factor-A (VEGF-A) gene expression in an experimental gentamicin-induced nephrotoxicity and ameliorative effect of caffeic acid phenethyl ester (CAPE) was investigated in rats. Animals were divided into four groups (n=8); control (C) group animals were given 10% dimethylsulfoxide (DMSO); gentamicin (G) group animals were given 100 mg/kg/day gentamicin; CAPE group animals were given 30 mg/kg/day CAPE and CAPE+G group animals were given 100 mg/kg/day gentamicin plus 30 mg/kg/day CAPE. Serum creatinine and BUN levels significantly increased in gentamicin group as compared to the control group (p0.05). Gene expression level of VEGF-A in gentamicin group significantly decreased as compared to the control group, however, CAPE treatment did not have any increasing effect on the gene expression level. According to histopathological investigation, gentamicin treatment caused prominent degeneration in kidney tissue and CAPE treatment had only slight beneficial effect on lowering the tissue degeneration. The results showed that gentamicin decreases VEGF-A gene expression and this might be related to the tissue degeneration at cellular level. However, CAPE treatment did not have significant ameliorative effect in lowering the gentamicin induced nephrotoxicity.

Collaboration


Dive into the Muslum Akgoz's collaboration.

Top Co-Authors

Avatar

Erkan Mozioğlu

Scientific and Technological Research Council of Turkey

View shared research outputs
Top Co-Authors

Avatar

Sema Akyürek

Scientific and Technological Research Council of Turkey

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ahmet C. Gören

Scientific and Technological Research Council of Turkey

View shared research outputs
Top Co-Authors

Avatar

Burhanettin Yalçınkaya

Scientific and Technological Research Council of Turkey

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jing Wang

Fred Hutchinson Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge